2/5/25 09:03 | 2/3/25 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S | -538 | 53.81 | 0 | -10 | -3 | 311 | D | | | | | | | | | | | | | | |
1/27/25 18:08 | 1/24/25 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | M.d | 274 | 6.36 | 0 | 43 | 15 | 321 | D | | | | | | | | | | | | | | |
1/6/25 14:08 | 1/2/25 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S | -280 | 28.03 | 0 | -10 | -3 | 278 | D | | | | | | | | | | | | | | |
12/12/24 20:38 | 12/10/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S | -77 | 30.79 | 0 | -3 | -1 | 264 | D | | | | | | | | | | | | | | |
12/4/24 19:34 | 12/2/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S | -321 | 32.13 | 0 | -10 | -4 | 266 | D | | | | | | | | | | | | | | |
11/5/24 09:04 | 11/1/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | M.d | 859 | 21.09 | 0 | 41 | 17 | 276 | D | | | | | | | | | | | | | | |
11/5/24 09:04 | 11/1/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S.d | -1,601 | 31.57 | 0 | -51 | -16 | 276 | D | | | | | | | | | | | | | | |
10/16/24 20:06 | 10/14/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | M.d | 844 | 21.09 | 0 | 40 | 16 | 286 | D | | | | | | | | | | | | | | |
10/16/24 20:06 | 10/14/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S.d | -1,206 | 30.15 | 0 | -40 | -12 | 286 | D | | | | | | | | | | | | | | |
10/3/24 20:09 | 10/1/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S | -282 | 28.18 | 0 | -10 | -3 | 286 | D | | | | | | | | | | | | | | |
9/13/24 17:16 | 9/10/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S | -15 | 26.18 | 0 | -1 | 0 | 296 | D | | | | | | | | | | | | | | |
9/5/24 16:08 | 9/3/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S | -134 | 26.72 | 0 | -5 | -2 | 297 | D | | | | | | | | | | | | | | |
8/2/24 21:32 | 8/1/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S | -134 | 26.75 | 0 | -5 | -2 | 302 | D | | | | | | | | | | | | | | |
7/2/24 18:55 | 7/1/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S | -117 | 23.40 | 0 | -5 | -2 | 307 | D | | | | | | | | | | | | | | |
6/13/24 18:13 | 6/11/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S | -57 | 22.64 | 0 | -3 | -1 | 311 | D | | | | | | | | | | | | | | |
6/5/24 17:05 | 6/3/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S | -96 | 19.29 | 0 | -5 | -2 | 313 | D | | | | | | | | | | | | | | |
5/2/24 21:07 | 5/1/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S | -101 | 20.15 | 0 | -5 | -2 | 318 | D | | | | | | | | | | | | | | |
4/3/24 18:55 | 4/1/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S | -122 | 24.38 | 0 | -5 | -1 | 587 | D | | | | | | | | | | | | | | |
3/15/24 16:42 | 3/13/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S | -18 | 28.33 | 0 | -1 | 0 | 328 | D | | | | | | | | | | | | | | |
3/5/24 17:16 | 3/1/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | M.d | 51 | 0.6150 | 0 | 83 | 34 | 329 | D | | | | | | | | | | | | | | |
12/29/23 20:30 | 12/27/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | M.d | 34 | 6.36 | 0 | 5 | 2 | 245 | D | | | | | | | | | | | | | | |
12/29/23 20:30 | 12/27/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S.d | -130 | 24.00 | 0 | -5 | -2 | 245 | D | | | | | | | | | | | | | | |
12/18/23 20:39 | 12/14/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S | -11 | 20.76 | 0 | -1 | 0 | 245 | D | | | | | | | | | | | | | | |
11/21/23 17:30 | 11/17/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S | -440 | 14.68 | 0 | -30 | -12 | 213 | D | | | | | | | | | | | | | | |
10/4/23 20:33 | 10/2/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | M.d | 10 | 21.10 | 0 | 0 | 0 | 243 | D | | | | | | | | | | | | | | |
10/4/23 20:33 | 10/2/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S.d | -25 | 51.10 | 0 | 0 | 0 | 243 | D | | | | | | | | | | | | | | |
9/25/23 20:28 | 9/13/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S | -28 | 50.34 | 0 | -1 | 0 | 243 | D | | | | | | | | | | | | | | |
6/15/23 21:35 | 6/13/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S | -30 | 55.16 | 0 | -1 | 0 | 244 | D | | | | | | | | | | | | | | |
1/5/23 17:56 | 1/3/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | M.d | 5 | 0.6150 | 0 | 9 | 4 | 245 | D | | | | | | | | | | | | | | |
1/5/23 17:56 | 1/3/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S.d | -480 | 54.64 | 0 | -9 | -3 | 245 | D | | | | | | | | | | | | | | |
12/28/22 18:30 | 12/27/22 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | M.d | 75 | 6.03 | 0 | 13 | 5 | 242 | D | | | | | | | | | | | | | | |
12/28/22 18:30 | 12/27/22 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S.d | -620 | 49.57 | 0 | -13 | -5 | 242 | D | | | | | | | | | | | | | | |
10/27/22 21:25 | 10/25/22 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | M.d | 80 | 6.36 | 0 | 13 | 6 | 223 | D | | | | | | | | | | | | | | |
10/27/22 21:25 | 10/25/22 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S.d | -559 | 44.72 | 0 | -13 | -5 | 223 | D | | | | | | | | | | | | | | |
1/11/22 16:40 | 1/7/22 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | M.d | 17 | 0.6150 | 0 | 28 | 14 | 223 | D | | | | | | | | | | | | | | |
11/5/21 16:17 | 11/3/21 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S.m | -607 | 24.28 | 0 | -25 | -11 | 196 | D | | | | | | | | | | | | | | |
9/3/21 16:38 | 9/1/21 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S | -301 | 24.04 | 0 | -13 | -5 | 221 | D | | | | | | | | | | | | | | |
7/19/21 16:43 | 7/15/21 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | M.d | 6 | 0.6150 | 0 | 9 | 4 | 233 | D | | | | | | | | | | | | | | |
6/2/21 16:06 | 6/1/21 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S | -80 | 26.24 | 0 | -3 | -1 | 224 | D | | | | | | | | | | | | | | |
5/4/21 16:06 | 5/3/21 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S | -93 | 30.56 | 0 | -3 | -1 | 227 | D | | | | | | | | | | | | | | |
4/5/21 17:15 | 4/1/21 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S | -88 | 28.75 | 0 | -3 | -1 | 230 | D | | | | | | | | | | | | | | |
3/2/21 17:56 | 3/1/21 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S | -93 | 30.48 | 0 | -3 | -1 | 233 | D | | | | | | | | | | | | | | |
2/2/21 16:08 | 2/1/21 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S | -89 | 29.24 | 0 | -3 | -1 | 236 | D | | | | | | | | | | | | | | |
1/11/21 19:54 | 1/7/21 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | M.d | 5 | 0.6150 | 0 | 8 | 3 | 239 | D | | | | | | | | | | | | | | |
1/11/21 19:54 | 1/8/21 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S.d | -281 | 28.12 | 0 | -10 | -4 | 239 | D | | | | | | | | | | | | | | |
1/6/21 18:48 | 1/4/21 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | S | -77 | 25.29 | 0 | -3 | -1 | 242 | D | | | | | | | | | | | | | | |
3/16/20 17:51 | 3/13/20 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | M.d | 7 | 0.6150 | 0 | 11 | 5 | 244 | D | | | | | | | | | | | | | | |
1/10/20 19:39 | 1/10/20 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | M.d | 24 | 0.6150 | 0 | 39 | 15 | 292 | D | | | | | | | | | | | | | | |